May 22, 2019 Measurement Comparability of Electronic and Paper Administered Visual Analogue Scales: A Review of Published Studies
May 16, 2019 Best Practices for Avoiding Paper Backup When Implementing Electronic Approaches to Patient-Reported Outcome Data Collection in Clinical Trials (May 16, 2019) This webinar provides an overview of the issues related to the use of paper backups in studies for which PRO data is collected ele
May 12, 2019 Parkinson’s Progression Markers Initiative (PPMI). Molecular Neuroimaging of the Dopamine Transporter as a Patient Enrichment Biomarker for Clinical Trials for Early Parkinson’s Disease
May 2, 2019 C-Path, CDISC Release Therapeutic Area Standard to Drive Research Forward for Clostridium Difficile Associated Diarrhea TUCSON, Ariz. and AUSTIN, May 2, 2019 — The Critical Path Institute (C-Path) and CDISC are pleased to announce the relea
May 1, 2019 Critical Path for Parkinson’s: Catalyzing Innovation for Parkinson’s Clinical Trials through Data Sharing and Regulatory Science. Stephenson D …et al. | American Academy of Neurology, Philadelphia, PA
April 24, 2019-April 25, 2019 Tenth Annual Patient-Reported Outcome Consortium Workshop WHAT: Tenth Annual Patient-Reported Outcome Consortium Workshop WHEN: April 24-25, 2019 WHERE: Sheraton Silver Sprin
April 24, 2019-April 25, 2019 Tenth Annual Patient-Reported Outcome Consortium Workshop April 24 – 25, 2019 Sheraton Silver Spring Hotel 8777 Georgia Avenue Silver Spring, MD 20910 On April 24-25, 2019 the Tenth Ann
April 16, 2019 C-Path, CDISC Develop Therapeutic Area Standard to Foster More Efficient and Meaningful Research for HIV TUCSON, Ariz. and AUSTIN, April 16, 2019 — The Critical Path Institute (C-Path) and CDISC are pleased to announce
April 9, 2019 C-Path Receives Qualification for the Asthma Daytime Symptom Diary (ADSD) and the Asthma Nighttime Symptom Diary (ANSD) TUCSON, Ariz., April 9, 2019 — Critical Path Institute’s (C-Path) Patient-Reported Outcome (PRO) Consortium announces U.S.
April 5, 2019 Muscular Dystrophy Association 2019 Clinical and Scientific Conference Jane Larkindale, Executive Director of D-RSC, attended the Muscular Dystrophy Association Clinical and Scientific Conference in Or